228 related articles for article (PubMed ID: 11586198)
1. Quantification of 5-aminolevulinic acid induced fluorescence improves the specificity of bladder cancer detection.
Zaak D; Frimberger D; Stepp H; Wagner S; Baumgartner R; Schneede P; Siebels M; Knüchel R; Kriegmair M; Hofstetter A
J Urol; 2001 Nov; 166(5):1665-8; discussion 1668-9. PubMed ID: 11586198
[TBL] [Abstract][Full Text] [Related]
2. Seven years' experience with 5-aminolevulinic acid in detection of transitional cell carcinoma of the bladder.
Hungerhuber E; Stepp H; Kriegmair M; Stief C; Hofstetter A; Hartmann A; Knuechel R; Karl A; Tritschler S; Zaak D
Urology; 2007 Feb; 69(2):260-4. PubMed ID: 17320660
[TBL] [Abstract][Full Text] [Related]
3. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence.
Kriegmair M; Baumgartner R; Knüchel R; Stepp H; Hofstädter F; Hofstetter A
J Urol; 1996 Jan; 155(1):105-9; discussion 109-10. PubMed ID: 7490803
[TBL] [Abstract][Full Text] [Related]
4. Detection of squamous cell carcinomas and pre-cancerous lesions in the oral cavity by quantification of 5-aminolevulinic acid induced fluorescence endoscopic images.
Zheng W; Soo KC; Sivanandan R; Olivo M
Lasers Surg Med; 2002; 31(3):151-7. PubMed ID: 12224087
[TBL] [Abstract][Full Text] [Related]
5. 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer.
Babjuk M; Soukup V; Petrík R; Jirsa M; Dvorácek J
BJU Int; 2005 Oct; 96(6):798-802. PubMed ID: 16153204
[TBL] [Abstract][Full Text] [Related]
6. Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy.
Kriegmair M; Zaak D; Rothenberger KH; Rassweiler J; Jocham D; Eisenberger F; Tauber R; Stenzl A; Hofstetter A
J Urol; 2002 Aug; 168(2):475-8. PubMed ID: 12131291
[TBL] [Abstract][Full Text] [Related]
7. Hexylaminolaevulinate 'blue light' fluorescence cystoscopy in the investigation of clinically unconfirmed positive urine cytology.
Ray ER; Chatterton K; Khan MS; Thomas K; Chandra A; O'Brien TS
BJU Int; 2009 May; 103(10):1363-7. PubMed ID: 19076151
[TBL] [Abstract][Full Text] [Related]
8. Oral 5-aminolevulinic acid in simultaneous photodynamic diagnosis of upper and lower urinary tract transitional cell carcinoma - a prospective audit.
Ahmad S; Aboumarzouk O; Somani B; Nabi G; Kata SG
BJU Int; 2012 Dec; 110(11 Pt B):E596-600. PubMed ID: 22758907
[TBL] [Abstract][Full Text] [Related]
9. [Fluorescent endoscopy superior to white light endoscopy. Detecting cancers of the urinary bladder earlier].
Zaak D
MMW Fortschr Med; 2002 Mar; 144(13):24-6. PubMed ID: 12001582
[TBL] [Abstract][Full Text] [Related]
10. [Fluorescence cystoscopy in the diagnostics and treatment of superficial urinary bladder tumors].
Babjuk M; Soukup V; Petrík R; Pavlík I; Jirsa M; Dvorácek J; Pecen L
Cas Lek Cesk; 2005; 144 Suppl 2():15-8. PubMed ID: 16277179
[TBL] [Abstract][Full Text] [Related]
11. Hexylaminolaevulinate fluorescence cystoscopy in patients previously treated with intravesical bacille Calmette-Guérin.
Ray ER; Chatterton K; Khan MS; Chandra A; Thomas K; Dasgupta P; O'Brien TS
BJU Int; 2010 Mar; 105(6):789-94. PubMed ID: 19832725
[TBL] [Abstract][Full Text] [Related]
12. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study.
Denzinger S; Burger M; Walter B; Knuechel R; Roessler W; Wieland WF; Filbeck T
Urology; 2007 Apr; 69(4):675-9. PubMed ID: 17445650
[TBL] [Abstract][Full Text] [Related]
13. [Fluorescent diagnostics of urinary bladder cancer].
Lopatkin NA; Kamalov AA; Kudriavtsev IuV; Tokarev FV
Urologiia; 2000; (4):3-6. PubMed ID: 11186690
[TBL] [Abstract][Full Text] [Related]
14. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study.
Jocham D; Witjes F; Wagner S; Zeylemaker B; van Moorselaar J; Grimm MO; Muschter R; Popken G; König F; Knüchel R; Kurth KH
J Urol; 2005 Sep; 174(3):862-6; discussion 866. PubMed ID: 16093971
[TBL] [Abstract][Full Text] [Related]
15. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study.
Daniltchenko DI; Riedl CR; Sachs MD; Koenig F; Daha KL; Pflueger H; Loening SA; Schnorr D
J Urol; 2005 Dec; 174(6):2129-33, discussion 2133. PubMed ID: 16280742
[TBL] [Abstract][Full Text] [Related]
16. Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy.
Schmidbauer J; Witjes F; Schmeller N; Donat R; Susani M; Marberger M;
J Urol; 2004 Jan; 171(1):135-8. PubMed ID: 14665861
[TBL] [Abstract][Full Text] [Related]
17. [ALA fluorescent diagnosis of bladder cancer].
Al'-Shukri SKh; Danil'chenko DI; Kënig F; Shnorr D
Urologiia; 2000; (5):48-50. PubMed ID: 11392226
[TBL] [Abstract][Full Text] [Related]
18. [The impact of ALA (5-aminolevulinic acid)-fluorescence detection on the prognosis of superficial bladder cancer].
Daniltchenko D; Riedl C; Koenig F; Daha LK; Sachs M; Schnorr D
Aktuelle Urol; 2004 Nov; 35(6):497-501. PubMed ID: 15526230
[TBL] [Abstract][Full Text] [Related]
19. Blue-sky thinking about blue-light cystoscopy.
Thomas K; O'Brien T
BJU Int; 2009 Oct; 104(7):887-9. PubMed ID: 19583718
[No Abstract] [Full Text] [Related]
20. [Role of fluorescent control in raising radicality of surgical treatment for superficial bladder cancer].
Matveev BP; Kudashev BV; Bukharkin BV; Romanov VA; Rubanov IuV
Urologiia; 2000; (3):22-4. PubMed ID: 11186703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
